Evidence 1
Activity
Activity
Tumor-homing Peptides
Target
Tumor cell
Homing
Lung, Breast, Colon, Prostate cancer
Gastrin-releasing peptide receptor
Source & Reference
TumorHoPe2.0
TumorHoPe2
Enhancing the circulating half-life and the antitumor effects of a tumor-selective cytotoxic peptide by exploiting endogenous serum albumin as a drug carrier
2016
Tao Su et al. Int J Pharm. 2016 Feb 29
499(1-2):195-204.
Other
| Source Activity Label | Source Definition |
|---|---|
| Tumor-homing Peptides |
TumorHoPe2.0
experimentally validated tumor-homing peptide annotation.
|
COLO 205, K562, and SMMC-7721 tumor cells
Female athymic 4–5-week-old BALB/c mice
Synthetic
ABB28 (albumin-binding domain fused to BB28), PEGylation (5K-BB28 and 10K-BB28)